Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
Tue, 18.06.2024       niiio finance group AG

niiio finance group AG: Ad-hoc reporting according to Art. 17 MARUpdate: Impairment at niiio finance group AG Görlitz, 18.6.2024 In connection with the audit of the annual accounts of financial year 2023 and in co-operation with the Company’s auditor, the executive board of niiio finance group AG has identified an additional requirement for impairm [ … ]
Tue, 18.06.2024       Verve Group SE (Nordic)

Verve announces intention to carry out a directed share issue NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM THE UNITED STATES (INCLUDING ITS TERRITORIES AND POSSESSIONS), EACH STATE OF THE UNITED STATES (INCLUDING THE DISTRICT OF COLUMBIA), AUSTRALIA, BELARUS, CANADA, [ … ]
Tue, 18.06.2024       Verve Group SE (Nordic)

Verve Acquires Jun Group, a Mobile First Digital Advertising Firm, Resulting in Combined, Pro Forma, €447m Revenues and €151m Adj. EBITDA, Reduced Leverage of 2.4x, Updated Mid-Term Financial Targets Verve Acquires Jun Group, a Mobile First Digital Advertising Firm, Resulting in Combined, Pro Forma, €447m Revenues and €151m Adj [ … ]
Tue, 18.06.2024       Affluent Medical SA

PRESS RELEASE Affluent Medical achieves the clinical objective of the Dry pilot study in the first two patients with the Artus artificial urinary sphincter Second successful implantation of the innovative Artus medical device in Krakow, Poland Successful activation of the Artus device in the first two patients six weeks after surgery Artus, an  [ … ]
Tue, 18.06.2024       Affluent Medical SA

PRESS RELEASE Affluent Medical achieves the clinical objective of the Dry pilot study in the first two patients with the Artus artificial urinary sphincter Second successful implantation of the innovative Artus medical device in Krakow, Poland Successful activation of the Artus device in the first two patients six weeks after surgery Artus, an  [ … ]
Tue, 18.06.2024       Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals 2024 Investor Day on June 25, 2024, in New York City   Three of the world’s leading key opinion leaders (KOL) in neuroscience and schizophrenia to review and present findings on Newron’s evenamide program for treatment-resistant schizophrenia   The company will host a Live-Webcast of the event, beginning at 9:00 AM EDT (2 [ … ]
Tue, 18.06.2024       tick Trading Software AG

Düsseldorf, 18.06.2024 - tick Trading Software AG (WKN: A35JS9 / ISIN: DE000A35JS99) has completed the first half of the 2023/2024 financial year (October 1, 2023 – March 31, 2024) with a net profit for the period of EUR 526 thousand (previous year: EUR 707 thousand) according to the half-yearly financial statements prepared today. Sales revenues  [ … ]
Tue, 18.06.2024       Adler Group S.A.

Bondholders clear the way for Adler Group’s comprehensive recapitalisation AGPS BondCo PLC receives overwhelming support in consent solicitations Major step towards stabilisation of the Group Luxembourg, 18 June 2024 – Bondholders of Adler Group S.A. (“Adler Group” and together with its subsidiaries, the “Group”) have cleared the way for the Grou [ … ]
Tue, 18.06.2024       Adler Group S.A.

Bondholders clear the way for Adler Group’s comprehensive recapitalisation AGPS BondCo PLC receives overwhelming support in consent solicitations Major step towards stabilisation of the Group Luxembourg, 18 June 2024 – Bondholders of Adler Group S.A. (“Adler Group” and together with its subsidiaries, the “Group”) have cleared the way for the Grou [ … ]
Tue, 18.06.2024       Heidelberg Pharma AG

Ad hoc announcement Disclosure of inside information under Article 17 of Regulation (EU) No 596/2014 Heidelberg Pharma AG Announces Updated Guidance Ladenburg, Germany, 18 June 2024 – Heidelberg Pharma AG (FSE: HPHA), a clinical stage biotech company developing innovative Antibody Drug Conjugates (ADCs), today announces that it has adjusted its  [ … ]

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
About the newsfeed
#1
Where does the information come from?

The information is provided as part of a content partnership by one of Europe's leading news data providers, the Munich-based EQS Group.

#2
Will editorial changes be made?
The portal site is part of the EQS-Newswire distribution network. The information is provided 'as is'. No editorial adjustments are made. The detailed views are enriched with additional information in order to offer interested investors further research options.
#3
From which news source does the information originate?
As a rule, it is the companies themselves that provide information, either through their own public relations work or via partner agencies. Due to the wide reach of the EQS distribution network and the associated multiplier effects, this service is often used to reach interested parties quickly and in a targeted manner. The EQS Group counts almost all listed companies among its customers.
#4
Are the messages provided in real time?

The data feeds are updated at regular intervals. You can obtain the latest information directly from EQS if required. Simply follow the link below.

#5
Are there plans to expand the scope of the news?

If investor-relevant topics are involved, it is possible to connect additional data providers. In Q1/2024, mwb Research was added to the information offering in the rating area.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Monday, 28.10.2024, Calendar Week 44, 302nd day of the year, 64 days remaining until EoY.